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To the editor: D’Hulst and Deldicque (1) argue that the severity of muscle atrophy incurred at 
high altitude is dependent on the combined effect of duration and degree of hypoxia exposure, 
or ‘hypoxic dose’ (1). We do see a limitation of this concept, as it implies that someone residing 
in Leuven (altitude: 28 m) for ten years would be subjected to a ‘hypoxic dose’ of 2454 km·h 
and incur 5% atrophy. While the authors wrote that ‘it is unknown which parameter, altitude or 
time spent at altitude, is most decisive in the overall metric of hypoxic dose’, our illustration 
suggests that altitude is the prime determinant. This is further supported by the cut-off point at 
4000 m in a plot of the degree of atrophy vs. altitude (using the data in Table 1), whereas there 
was no clear relationship with duration of altitude residence. This cut-off point is likely related 
to the shape of the hemoglobin dissociation curve, where the oxygen tension at 4000 m is such 
that physiologically significant arterial hemoglobin desaturation occurs (2). We acknowledge 
that one cannot entirely dismiss the importance of duration of hypoxic exposure, simply 
because skeletal muscle atrophy can only be noticed some time after net protein breakdown 
is initiated. However, muscle atrophy will not continue indefinitely, but will reach a new steady 
state (how can otherwise Tibetans still have muscle?). Finally, other adaptations than atrophy, 
such as an increase in hematocrit and capillarization, serve to attenuate muscle tissue hypoxia 
and atrophy (3) during residence at altitude. 
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